AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Adherence to Prescribed Therapy for Lung Cancer: AscellaHealth Clinical & Educational Programs Extend High-Touch Specialty Pharmacy Solutions, Lower Costs

November 6, 2019 GMT

BERWYN, Pa.--(BUSINESS WIRE)--Nov 6, 2019--

In recognition of November as Lung Cancer Awareness Month, AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, urges all Americans to join efforts to raise awareness for the need for more research and better community awareness of this disease. AscellaHealth points to the complexity and collaboration required in the management of lung cancer, underscoring the role of AscellaHealth’s clinical and educational programs to assist members with their prescribed therapy.

“Every 3.3 minutes someone in the U.S. dies of lung cancer. Lung cancer accounts for more deaths than any other cancer, including breast, prostate and colon cancer combined,” explains says Dea Belazi, president and CEO, AscellaHealth. “This highlights the critical need to help members -- beginning on day one of diagnosis -- with high deductible/co-insurance costs. Our programs provide members with information and support for utilizing financial assistance options and introduce opportunities to partner with physicians and pharmacists as they undergo the course of treatment.”

The AscellaHealth strategic approach to specialty pharmacy is designed to improve outcomes and care coordination required in the treatment of serious diseases, including lung cancer. A high-touch model includes clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination as part of AscellaHealth’s innovative specialty pharmacy strategy.

“These touch points really make the difference for each and every member, and this November, we want to reach an even greater number of members battling lung cancer,” says Belazi. “By reducing costs, including discounted prices, we create exceptional value for both payers and patients and make a significant contribution to improving patient engagement and the overall healthcare experience.”

AscellaHealth’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting.

About AscellaHealth

AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191106005023/en/

CONTACT: Media:

Nicole Dufour

CPR Communications

ndufour@cpronline.com

201.641.1911 x 54

KEYWORD: PENNSYLVANIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: OTHER HEALTH HEALTH PHARMACEUTICAL MANAGED CARE ONCOLOGY

SOURCE: AscellaHealth

Copyright Business Wire 2019.

PUB: 11/06/2019 10:00 AM/DISC: 11/06/2019 10:01 AM

http://www.businesswire.com/news/home/20191106005023/en